Monday, November 30, 2020 8:04:48 PM
https://www.theportugalnews.com/news/2020-11-27/covid-pcr-test-reliability-doubtful-portugal-judges/56962
The controversial ruling claimed that the PCR test was unreliable with a Ct of 35, with only 3% true positive at that high cycle threshold of PCR amplification. It cited this study:
https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa1491/5912603
There is a lot to be learned about the quality of PCR testing if high Cts are used, especially whether or not someone is infectious if they have a low viral load (high Ct), or is the positive "false" in the sense of no active disease, just dead viral fragments that are harmless to the infected and those they come into contact with.
Some of the ID doctors I've talked to feel that if one can't culture a virus it likely isn't infectious. (Except that some viruses are known to be very hard to culture, and this general rule doesn't apply).
In general, I think officials are bringing down the duration of required quarantine from 14 days. It's really amazing how many different "rules" people have for quarantine, travel, what is a low risk versus high risk exposure, and how all the rules have changed over time, including at my health care facility.
Kids seem to get mild versions of Covid (if any symptoms) and I hear they don't seem to spread it as much as others, either.
In any event, it's good to be careful as long as people aren't being harmed by it. Can't wait for that brilacidin trial to start. Hopefully it will enroll quickly. Once again it will be hard to maintain the blind (as before for ABSSSI) since IV-brilacidin causes temporary tingling in the extremities.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM